https___www.newser.com_story_261905_47b-awarded-in-groundbreaking-talc-powder-lawsuit.html.xml
https___ratopati.com_story_257260_2022_8_13_johnson-and-johnson-_1.xml
1.1 1.2 1.3 1.4 2.1 2.2 2.3 2.4 2.5 3.1 4.1
A St. Louis jury on Thursday awarded nearly $4.7 billion in total damages to 22 women and their families after they claimed asbestos in Johnson & Johnson talcum powder contributed to their ovarian cancer. This was the first case against the company that focused on asbestos in the powder, the AP reports. The jury announced the $4.14 billion award in punitive damages shortly after awarding $550 million in compensatory damages. Johnson & Johnson called the verdict the result of an unfair process that allowed the women to sue the company in Missouri despite most of them not living in the state and said it would appeal, as it has in previous cases that found for women who sued the company. "Johnson & Johnson remains confident that its products do not contain asbestos and do not cause ovarian cancer" and intends to appeal, spokeswoman Carol Goodrich said. Mark Lanier, lead counsel for the plaintiffs, said in a statement that Johnson & Johnson had covered up evidence of asbestos in their products for more than 40 years. Medical experts testified during the trial that asbestos, a known carcinogen, is intermingled with mineral talc, which is the primary ingredient in Johnson & Johnson's Baby Powder and Shower to Shower products. The plaintiffs' lawyers said asbestos fibers and talc particles were found in the ovarian tissues of many of the women. "The company should pull talc from the market before causing further anguish, harm, and death from a terrible disease," Lanier said. (Read more Johnson & Johnson stories.)
1.1 2.1 3.1 4.1 5.1 6.1 7.1 8.1
जोन्सन एन्ड जोन्सनले बेबी पाउडर उत्पादन र बिक्री पूर्ण रूपमा बन्द गर्ने जोन्सन एन्ड जोन्सनले अर्को वर्षदेखि बेबी पाउडर उत्पादन र बिक्री पूर्ण रूपमा बन्द गर्ने भएको छ । अमेरिकामा यो पाउडरको बिक्री बन्द गरेको दुई वर्षपछि हेल्थकेयर कम्पनीले यो निर्णय गरेको हो । जोन्सन एन्ड जोन्सनले आफ्ना उत्पादनहरूमा एस्बेस्टोस प्रयोग गर्ने र त्यसले पाठेघरको क्यान्सर गराएको आरोप लगाउँदै महिलाहरूले कम्पनी विरुद्ध करिब ३८,००० मुद्दाहरू दायर गरेका छन् । तर कम्पनीले दशकौँको अनुसन्धानले आफ्ना उत्पादनहरू प्रयोग गर्न सुरक्षित रहेको देखाएको दाबी गरेको छ। कर्नस्टार्चमा आधारित पाउडर विश्वका विभिन्न देशमा बिक्री भइसकेको पनि कम्पनीले जनाएको छ । कमेन्ट कमेन्ट गर्नुहोस् तपाईको ईमेल गोप्य राखिनेछ यो पनि पढौँ रातोपाटीको अंग्रेजी, हिन्दी र ग्लोबल संस्करणका साथै अनलाइन टिभी पनि सञ्चालित छ । एप्सबाट सिधै समाचार पढ्न एन्ड्रोइडका लागि यहाँ र आइफोनका लागि यहाँ क्लिक गर्नुहोस् । फेसबुक र ट्वीटरमार्फत पनि हामीसँग जोडिन सकिनेछ ।